CVS Health Corporation (NYSE:CVS) Updates Q3 Earnings Guidance
CVS Health Corporation (NYSE:CVS) issued an update on its third quarter earnings guidance on Tuesday morning. The company provided earnings per share guidance of $1.47-1.50 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.63. CVS Health Corporation also updated its FY17 guidance to $5.83-5.93 EPS.
CVS Health Corporation (NYSE CVS) opened at 79.12 on Tuesday. CVS Health Corporation has a 52 week low of $69.30 and a 52 week high of $98.44. The company has a market capitalization of $80.61 billion, a price-to-earnings ratio of 16.50 and a beta of 0.91. The company’s 50-day moving average price is $78.75 and its 200-day moving average price is $79.09. CVS Health Corporation also saw unusually large options trading on Monday. Traders bought 12,222 put options on the stock. This represents an increase of 254% compared to the average daily volume of 3,454 put options.
CVS Health Corporation (NYSE:CVS) last posted its quarterly earnings data on Tuesday, August 8th. The pharmacy operator reported $1.33 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.31 by $0.02. CVS Health Corporation had a return on equity of 17.56% and a net margin of 2.86%. The company had revenue of $45.69 billion during the quarter, compared to analyst estimates of $45.36 billion. During the same period in the previous year, the business earned $1.32 EPS. CVS Health Corporation’s quarterly revenue was up 4.5% on a year-over-year basis. Equities analysts forecast that CVS Health Corporation will post $5.87 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Thursday, August 3rd. Stockholders of record on Monday, July 24th were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.53%. The ex-dividend date was Thursday, July 20th. CVS Health Corporation’s dividend payout ratio is currently 41.67%.
Several research analysts have recently weighed in on CVS shares. Tigress Financial started coverage on CVS Health Corporation in a report on Thursday, April 27th. They set a buy rating on the stock. Vetr cut CVS Health Corporation from a buy rating to a hold rating and set a $85.78 target price on the stock. in a report on Thursday, April 27th. Evercore ISI restated an outperform rating and set a $88.00 target price (up from $87.00) on shares of CVS Health Corporation in a report on Wednesday, May 3rd. ValuEngine cut CVS Health Corporation from a buy rating to a hold rating in a report on Friday, June 2nd. Finally, Jefferies Group LLC restated a hold rating and set a $82.00 target price on shares of CVS Health Corporation in a report on Friday, June 9th. Nine equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. The company currently has an average rating of Buy and a consensus target price of $92.20.
In related news, EVP Helena Foulkes sold 20,332 shares of the stock in a transaction on Monday, June 19th. The stock was sold at an average price of $76.98, for a total value of $1,565,157.36. Following the transaction, the executive vice president now owns 59,300 shares of the company’s stock, valued at $4,564,914. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO David M. Denton sold 230,510 shares of the stock in a transaction on Monday, June 12th. The shares were sold at an average price of $80.00, for a total value of $18,440,800.00. Following the completion of the transaction, the chief financial officer now directly owns 176,983 shares in the company, valued at approximately $14,158,640. The disclosure for this sale can be found here. Insiders sold 271,175 shares of company stock worth $21,632,597 in the last three months. 0.61% of the stock is currently owned by corporate insiders.
ILLEGAL ACTIVITY WARNING: This story was first reported by American Banking News and is the property of of American Banking News. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of US & international copyright legislation. The correct version of this story can be read at https://www.americanbankingnews.com/2017/08/08/cvs-health-corporation-nysecvs-updates-q3-earnings-guidance.html.
CVS Health Corporation Company Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.